Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function
- PMID: 17955185
- DOI: 10.1007/s11095-007-9469-z
Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function
Abstract
Purpose: Mechanism for double-peak occurrence in plasma concentration profile after oral administration of drugs is controversial, although irregular gastric emptying would be an important factor. The objective of this study was to assess the effect of gastric emptying and a weight function, i.e. pharmacokinetics after reaching the systemic circulation, on the double-peak appearance in plasma concentration profiles.
Materials and methods: Alprazolam, which generates irregular gastric emptying, was orally co-administered with theophylline to rats, and the plasma concentration profiles or absorption rates were compared between the two drugs. Both drugs are highly absorbable, but alprazolam is rapidly eliminated from plasma, while the elimination of theophylline is very slow.
Results: Oral administration of alprazolam generated the irregular gastric emptying profiles, resulting in multiple peaks in the absorption rate profiles of both drugs. The double peaks in the absorption rate profiles led to the double peaks in plasma concentration profiles for alprazolam, but not necessarily for theophylline. Simulation study clearly indicated that the slower elimination from plasma made the first peak less recognizable.
Conclusions: The irregular gastric emptying could be a main reason for the double peaks in plasma concentration profiles. However, the frequency of double-peak occurrence depends on the weight function, particularly the elimination rate, of each drug.
Similar articles
-
Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in rat.J Pharmacokinet Pharmacodyn. 2008 Feb;35(1):1-30. doi: 10.1007/s10928-007-9073-1. Epub 2007 Oct 26. J Pharmacokinet Pharmacodyn. 2008. PMID: 17963025
-
Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pH.Biopharm Drug Dispos. 1994 Dec;15(9):719-46. doi: 10.1002/bdd.2510150902. Biopharm Drug Dispos. 1994. PMID: 7888602
-
The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon.J Pharmacokinet Biopharm. 1987 Oct;15(5):529-44. doi: 10.1007/BF01061761. J Pharmacokinet Biopharm. 1987. PMID: 3694496
-
Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.Mol Pharm. 2009 Sep-Oct;6(5):1429-40. doi: 10.1021/mp9000876. Mol Pharm. 2009. PMID: 19655809 Review.
-
Clinical pharmacokinetics of alprazolam. Therapeutic implications.Clin Pharmacokinet. 1993 Jun;24(6):453-71. doi: 10.2165/00003088-199324060-00003. Clin Pharmacokinet. 1993. PMID: 8513649 Review.
Cited by
-
An effective UFLC-MS/MS method used to study pharmacokinetics of major constituents of Fukeqianjin formula in rat plasma.Chin Med. 2020 Jul 25;15:74. doi: 10.1186/s13020-020-00347-5. eCollection 2020. Chin Med. 2020. PMID: 32724332 Free PMC article.
-
Pharmacokinetics Studies of 12 Alkaloids in Rat Plasma after Oral Administration of Zuojin and Fan-Zuojin Formulas.Molecules. 2017 Jan 30;22(2):214. doi: 10.3390/molecules22020214. Molecules. 2017. PMID: 28146096 Free PMC article.
-
Development and validation of the HPLC-MS/MS method and its application to the pharmacokinetic study for the Mongolian drug Sendeng-4 in rat blood plasma.Front Pharmacol. 2025 Mar 19;16:1547415. doi: 10.3389/fphar.2025.1547415. eCollection 2025. Front Pharmacol. 2025. PMID: 40176895 Free PMC article.
-
Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.Int J Nanomedicine. 2013;8:4415-26. doi: 10.2147/IJN.S51469. Epub 2013 Nov 19. Int J Nanomedicine. 2013. PMID: 24277986 Free PMC article.
-
Preclinical Bioavailability, Tissue Distribution, and Protein Binding Studies of Erinacine A, a Bioactive Compound from Hericium erinaceus Mycelia Using Validated LC-MS/MS Method.Molecules. 2021 Jul 27;26(15):4510. doi: 10.3390/molecules26154510. Molecules. 2021. PMID: 34361662 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources